mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.7 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
681640 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.7 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |